THE PHARMACOKINETICS OF ANTIPYRINE IN PATIENTS WITH GRADED SEVERITY OF SCHISTOSOMIASIS

被引：19

作者：

ELRAGHY, I

BACK, DJ

OSMAN, F

NAFEH, MA

ORME, ML

机构：

[1] UNIV LIVERPOOL,DEPT PHARMACOL & THERAPEUT,POB 147,LIVERPOOL L69 3BX,ENGLAND

[2] UNIV ASSIUT,DEPT PHARMACOL,ASSIUT,EGYPT

来源：

关键词：

D O I：

10.1111/j.1365-2125.1985.tb05069.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：313 / 316

页数：4

共 17 条

[1] EFFECT OF CHLOROQUINE AND PRIMAQUINE ON ANTIPYRINE METABOLISM
BACK, DJ
PURBA, HS
PARK, BK
WARD, SA
ORME, ML
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 16 (05) : 497 - 502
[2] PROTEIN-BINDING AND KINETICS OF DRUGS IN LIVER-DISEASES
BLASCHKE, TF
[J]. CLINICAL PHARMACOKINETICS, 1977, 2 (01) : 32 - 44
[3] BRANCH R A, 1976, Clinical Pharmacokinetics, V1, P264
[4] DETERMINANTS OF SERUM ANTIPYRINE HALF-LIVES IN PATIENTS WITH LIVER-DISEASE
BRANCH, RA
HERBERT, CM
READ, AE
[J]. GUT, 1973, 14 (07) : 569 - 573
[5] Brant P C, 1979, Rev Inst Med Trop Sao Paulo, V21, P254
[6] CHA YN, 1976, J PHARMACOL EXP THER, V199, P432
[7] DANESHMEND TK, 1983, BRIT J CLIN PHARMACO, V15, pP611
[8] DANESHMEND TK, 1982, BRIT J CLIN PHARMACO, V14, pP152
[9] ETHANOL AND ANTIPYRINE CLEARANCE
DOSSING, M
ANDREASEN, PB
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (01) : 101 - 104
[10] DUNN M A, 1981, Hepatology, V1, P653, DOI 10.1002/hep.1840010615